Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
1 extracted signal · 1 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 06 Oct 2025, 20:40 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
AMD, now termed "Advanced Money Dispenser", has surged 26% following an Open AI partnership. The analyst updates the price target to $531.66 per share based on EPS growth estimates. This is based on a 70% EPS growth in 2026 attributed to Open AI partnership, later years EPS growth: 35%, 30%, 25%, 20%. The analysis highlights the Open AI partnership as a game changer, offering AI chips to OpenAI, and potentially generating tens of billions in annual revenue. Revenue recognition will start next year. Open AI's warrants to acquire up to 10% of AMD at $0.01 per share, linked to price milestones (final tranch at $600) is designed to secure OpenAI's commitment. This amounts to massive additional revenue, as it represents about a three times the current value of share price now. The video mentions that analyst aren't fans of the warrant dilution at 1 cent per share, which is bad for market capitalization.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
